TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Life Science Strategics AS
Closing information (x1000 EUR)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
62
|
50
|
66 |
| Financial expenses |
1
|
1
|
2 |
| Earnings before taxes |
44
|
31
|
46 |
| Total assets |
103
|
98
|
111 |
| Current assets |
103
|
98
|
111 |
| Current liabilities |
37
|
36
|
41 |
| Equity capital |
67
|
63
|
71 |
| - share capital |
9
|
9
|
10 |
| Employees (average) |
1
|
1
|
1 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
65.0%
|
64.3%
|
64.0% |
| Turnover per employee |
62
|
50
|
66 |
| Profit as a percentage of turnover |
71.0%
|
62.0%
|
69.7% |
| Return on assets (ROA) |
43.7%
|
32.7%
|
43.2% |
| Current ratio |
278.4%
|
272.2%
|
270.7% |
| Return on equity (ROE) |
65.7%
|
49.2%
|
64.8% |
| Change turnover |
15
|
-12
|
16 |
| Change turnover % |
32%
|
-19%
|
32% |
| Chg. No. of employees |
0
|
0 | |
| Chg. No. of employees % |
0%
|
0% |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.